Currently, a lot of previous studies have reported that genes SERPINB5, CHD4, TCN1, VNN1, EPHA4, PCSK1, and DUOX2 as prognostic biomarkers were proven to correlate with poor tumor response and survival prognosis in patients with rectal cancer receiving pCRT [8–14]. This evidence concerns the gene VNN1 and rectal cancer.